NCT01326871 · OUTCOME

Maximum Tolerated Dose (MTD) and/or the Recommended Dose (RD) for Dose Expansion of ALT-801 in Combination With Cisplatin and Gemcitabine or ALT-801 in Combination With Gemcitabine Alone

A Study of ALT-801 in Combination With Cisplatin and Gemcitabine in Muscle Invasive or Metastatic Urothelial Cancer · Source last updated 2024-06-25

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure: NUMBER
Unit: mg/kg Recommended Dose
Interval / dispersion: Not reported
Time frame: 8 weeks

Groups in this outcome

ALT-801: 0.04 mg/kg, 0.06 mg/kg

Recommended dose is ALT-801 0.06 mg/kg

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

Group	Source count
ALT-801: 0.04 mg/kg, 0.06 mg/kg	9

Reported measurements

Source class 1

Values in mg/kg Recommended Dose · Interval/dispersion: Not reported
Group	Value	Spread	Lower	Upper	Comment
ALT-801: 0.04 mg/kg, 0.06 mg/kg	0.06	Not reported	Not reported	Not reported	Not reported

Complete source fields

classes

categories
measurements
group Id
OG000
value
0.06

denoms

counts
group Id
OG000
value
9
units
Participants

groups

description
Recommended dose is ALT-801 0.06 mg/kg
id
OG000
title
ALT-801: 0.04 mg/kg, 0.06 mg/kg

param Type

NUMBER

reporting Status

POSTED

time Frame

8 weeks

title

Maximum Tolerated Dose (MTD) and/or the Recommended Dose (RD) for Dose Expansion of ALT-801 in Combination With Cisplatin and Gemcitabine or ALT-801 in Combination With Gemcitabine Alone

type

PRIMARY

unit Of Measure

mg/kg Recommended Dose

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice